Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07514754 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer Patients

Study acronym: GALENOS 2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
GALENOS 2 is a single-arm, single-center, phase II interventional study designed to evaluate the effects of a galenic immunonutrition dietary supplement in patients with head and neck squamous cell carcinoma, locally advanced rectal cancer, or lung cancer undergoing standard antineoplastic treatment. The study aims to assess whether the formula may reduce treatment-related toxicity and improve treatment compliance, using patients from the GALENOS 1 observational study as the control group for comparison
Trial Details
NCT Number NCT07514754
Lead Sponsor Fondazione del Piemonte per l'Oncologia
Conditions
(from sponsor)		 Head and Neck Squamous Cell Carcinoma, Locally Advanced Rectal Cancer, Lung Cancer
Related terms Lung Neoplasms, Squamous Cell Carcinoma of Head and Neck
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov